Viral-based myocardial gene therapy approaches to alter cardiac function

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Gene Therapy

Background:

• Human physiology is increasingly understood at the molecular level, revealing pathways involved in cardiac disease.
• Current molecular tools to address cardiac pathophysiology are limited.
• Gene therapy holds promise for correcting molecular derangements causing illness.

Purpose of the Study:

• To highlight the challenges and potential of gene therapy in cardiovascular medicine.
• To emphasize the critical role of gene delivery methods.
• To explore the application of gene therapy in treating heart conditions.

Main Methods:

• Review of current understanding in molecular cardiology.
• Discussion of gene delivery strategies, focusing on viral vectors.
• Examination of preclinical and clinical studies involving gene therapy for heart disease.

Main Results:

• Viral vectors are the most successful gene delivery method to date.
• Gene therapy using viral vectors has shown benefit in human ischemic heart disease.
• Animal models suggest gene therapy can improve cardiac function in heart failure.

Conclusions:

• Reliable gene delivery to the heart is crucial for clinical gene therapy.
• Gene therapy, particularly with viral vectors, shows significant therapeutic potential for cardiovascular diseases.
• Further research is needed to overcome challenges in gene delivery for widespread clinical application.